Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Julia C.F. Quintanilha"'
Autor:
Julia C.F. Quintanilha, Alexander B. Sibley, Yingmiao Liu, Donna Niedzwiecki, Susan Halabi, Layne Rogers, Bert O’Neil, Hedy Kindler, William Kelly, Alan Venook, Howard L. McLeod, Mark J. Ratain, Andrew B. Nixon, Federico Innocenti, Kouros Owzar
Publikováno v:
BMC Genomics, Vol 25, Iss 1, Pp 1-10 (2024)
Abstract Background Herein, we report results from a genome-wide study conducted to identify protein quantitative trait loci (pQTL) for circulating angiogenic and inflammatory protein markers in patients with metastatic colorectal cancer (mCRC). The
Externí odkaz:
https://doaj.org/article/363d6f8837684c528d797df314a685cf
Autor:
Helen Y. Hougen, Ryon P. Graf, Gerald Li, Julia C.F. Quintanilha, Douglas I. Lin, Jeffrey S. Ross, Sanoj Punnen, Brandon A. Mahal
Publikováno v:
European Urology Open Science, Vol 55, Iss , Pp 45-49 (2023)
Tumor mutational burden (TMB) is a biomarker that predicts response to immune checkpoint inhibitor therapy. We currently lack a comprehensive understanding of how genomic and clinical factors correlate with TMB. We used a clinicogenomic database to a
Externí odkaz:
https://doaj.org/article/0fa74f08ce914662b98f2144737c5863
Autor:
Julia C.F. Quintanilha, Amy S. Etheridge, Brady J. Graynor, Nicholas B. Larson, Daniel J. Crona, Braxton D. Mitchell, Federico Innocenti
Publikováno v:
Clinical pharmacology and therapeutics. 112(2)
Hypertension is a common bevacizumab-induced toxicity. No markers are available to predict patients at risk of developing hypertension. We hypothesized that genetic risk of essential hypertension, as measured by a blood pressure polygenic risk score
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3e0db59441267e79147ff38f3dbd28b
https://pubmed.ncbi.nlm.nih.gov/35527502
https://pubmed.ncbi.nlm.nih.gov/35527502